Gerard Peter Moloney

Title: Innovations of Gerard Peter Moloney

Introduction

Gerard Peter Moloney is an accomplished inventor based in West Brunswick, Australia. He has made significant contributions to the field of biotechnology, particularly in the development of compounds that modulate Fc receptor activity. With a total of two patents to his name, Moloney's work is paving the way for advancements in the treatment of autoimmune diseases.

Latest Patents

Moloney's latest patents focus on Fc receptor modulating compounds and compositions. The inventions provide compounds capable of binding to an Fc receptor and modulating its activity. These compounds feature a core lipophilic group in the form of an Aryl ring, which is substituted with a group rich in p-electrons. The patents also outline methods for treating autoimmune diseases that involve Fc receptor activity using these compounds. Additionally, a method for obtaining such compounds is described, which includes providing or designing compounds with structural characteristics that fit in the groove of the FcγRIIa structure and screening them for modulating activity on the Fc receptor.

Career Highlights

Gerard Peter Moloney is currently associated with Trillium Therapeutics Inc., where he continues to innovate in the field of biotechnology. His work has garnered attention for its potential impact on therapeutic approaches to autoimmune diseases.

Collaborations

Some of his notable coworkers include Mark Phillip Hogarth and Geoffrey Allan Pietersz, who contribute to the collaborative efforts in research and development at Trillium Therapeutics Inc.

Conclusion

Gerard Peter Moloney's contributions to the field of biotechnology through his innovative patents and collaborations highlight his role as a significant inventor in the industry. His work continues to inspire advancements in the treatment of autoimmune diseases.